Genomatics® with the power of AI !

Genomatics was founded with a clear purpose: to build meaningful bioinformatics and genomics products that make complex biological knowledge easier to access, interpret and use.

From the beginning, our focus has been on the intersection of genomics, computational biology, literature intelligence, clinical interpretation and software engineering.

We believed that the explosion of genomic sequencing data would create an urgent need for reliable tools that could connect genes, variants, diseases, drugs and scientific evidence in a structured and usable way.

Today, that belief is stronger than ever.

From Genomic Big Data to Genomic Intelligence

Advances in sequencing technologies have created a vast and rapidly expanding world of genomic data. Human genome sequencing projects across the world have transformed our understanding of genes, variants, inherited disorders, cancer, rare diseases, pharmacogenomics and precision medicine.

But data alone is not enough.

For genomic information to be useful in research, diagnostics or clinical decision-making, it must be carefully extracted, curated, validated, organized and presented in a way that experts can trust. Scientific publications, variant databases, clinical observations and molecular evidence must be connected with discipline and context.

Genomatics was created to solve this problem.

Our Foundation: Human-Curated Genomic Knowledge

One of the earliest and strongest assets built by Genomatics is VarDiG-DB, a carefully curated genomic variants database created through a combination of scientific expertise, structured workflows, quality control and software-assisted curation.

Our team worked on extracting meaningful variant-level knowledge from biomedical literature, covering important relationships among:

Genes Variants Diseases Drugs Phenotypes Publications Clinical Evidence

This work required patience, scientific diligence and rigorous attention to detail. Manual curation in genomics is not simply data entry. It requires domain understanding, quality control, interpretation of scientific context and careful validation of evidence.

Genomatics built software pipelines, machine learning tools and backend systems to support this human curation process and improve the quality, speed and consistency of variant knowledge generation.

Building Products for Ease of Use

Genomics is complex. Our goal has always been to make it more usable.

Genomatics developed web-based tools and SaaS-style interfaces to help users search, explore and interpret variant knowledge through simple, accessible systems. Instead of leaving valuable scientific knowledge buried inside publications or spreadsheets, our products were designed to bring structured genomic evidence to the user through clean search, filters, associations and reports.

Powerful science should be supported by simple, usable systems.

Whether the user is a researcher, clinician, diagnostic laboratory, bioinformatician or healthcare organization, the system must reduce friction and help them reach meaningful answers faster.

Entering the AI Era

Genomatics is now evolving into the next phase: AI-assisted genomic intelligence.

The rapid progress of artificial intelligence has opened new possibilities in biomedical literature extraction, clinical evidence navigation, variant interpretation, knowledge summarization and decision support. But in a domain as sensitive as genomics and healthcare, AI cannot be treated as a casual black box.

Our approach is based on responsible AI:

  • Human-in-the-loop validation
  • Evidence-based outputs
  • Traceable scientific references
  • Domain-aware workflows
  • Quality-controlled knowledge extraction
  • Ease of use for clinicians, researchers and laboratories
  • Systems that support experts rather than replace them

We are building AI-driven products that combine the speed of modern machine intelligence with the reliability of curated scientific knowledge.

Our New Direction

The new generation of Genomatics work focuses on creating AI-enabled systems for genomic and biomedical intelligence. These include tools for genomic entity extraction, variant evidence navigation, clinical question answering, research acceleration and structured biomedical knowledge discovery.

Our AI work is not just about automation. It is about building better systems.

Systems that help users:

  • Extract knowledge from scientific publications
  • Understand gene, variant and disease relationships
  • Navigate clinical and molecular evidence
  • Reduce manual effort in literature review
  • Improve interpretation workflows
  • Generate structured summaries and reports
  • Use genomic evidence with greater clarity and confidence

We are especially committed to building products that are practical, elegant and usable — tools that reduce complexity rather than adding another layer of confusion.

Why Genomatics Exists

Genomatics exists because genomic knowledge is too important to remain scattered, inaccessible or difficult to interpret.

We believe the future of genomics will be driven by the right combination of:

Strong scientific foundations
Curated knowledge
Responsible AI
User-friendly software
Secure and scalable systems
Clinical and research relevance

Our journey began with variant curation and bioinformatics products. It now continues into AI-powered genomic intelligence, with the same commitment to diligence, quality and meaningful innovation.

Genomatics remains dedicated to building products that help researchers, clinicians, laboratories and healthcare organizations unlock the value of genomic knowledge — with clarity, confidence and care.